These advances can improve the quality of life for the patient during treatment. And for many types of cancer, improve targeting, reduce recurrence, and improve survival rates,” said May Abdel-Wahab, Director of the IAEA’s Human Health Division. “In addition, some of these new technologies, such as stereotactic body radiation therapy (SBRT), may complement new immunotherapy treatments by enhancing the immunogenicity of the cancer.
About this news: This represents a significant milestone in NESRO's journey to advance cancer care in Nepal and strengthen international collaborations.
Image Gallery
